Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes

被引：23

作者：

Zhang, Xuqing ^{[1
]}

Cai, Chaozhong ^{[1
]}

Sui, Zhihua ^{[1
]}

Macielag, Mark ^{[1
]}

Wang, Yuanping ^{[1
]}

Yan, Wen ^{[1
]}

Suckow, Arthur ^{[1
]}

Hua, Hong ^{[1
]}

Bell, Austin ^{[1
]}

Haug, Peter ^{[1
]}

Clapper, Wilma ^{[1
]}

Jenkinson, Celia ^{[1
]}

Gunnet, Joseph ^{[1
]}

Leonard, James ^{[1
]}

Murray, William V. ^{[1
]}

机构：

[1] Janssen Res & Dev LLC, Cardiovasc & Metab Res, Welsh & McKean Rd,Box 776, Spring House, PA 19477 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2017年 / 8卷 / 09期

关键词：

GPR120; phenylpropanoic acid; type; 2; diabetes; RECEPTOR; 4; FFA4/GPR120; INSULIN-RESISTANCE; FATTY-ACIDS; POTENT; IDENTIFICATION; RODENTS; DESIGN; MICE;

D O I：

10.1021/acsmedchemlett.7b00233

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We have discovered a novel series of isothiazole-based phenylpropanoic acids as GPR120 agonists. Extensive structure activity relationship studies led to the discovery of a potent GPR120 agonist 4x, which displayed good EC50 values in both calcium and beta-arrestin assays. It also presented good pharmaceutical properties and a favorable PK profile. Moreover, it demonstrated in vivo antidiabetic activity in C57BL/6 DIO mice. Studies in WT and knockout DIO mice showed that it improved glucose handling during an OGTT via GPR120. Overall, 4x possessed promising antidiabetic effect and good safety profile to be a development candidate.

引用

页码：947 / 952

页数：6

共 39 条

[1] Discovery of isothiazole-and thiophene-containing phenylpropanoic acids as potent and orally efficacious GPR120 agonists for the treatment of type 2 diabetes
Zhang, Xuqing
Cai, Chaozhong
Sui, Zhihua
Macielag, Mark
Wang, Yuanping
Yan, Wen
Suckow, Arthur
Hua, Hong
Bell, Austin
Haug, Peter
Clapper, Wilma
Jenkinson, Celia
Gunnet, Joseph
Leonard, James
Murray, William
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[2] Discovery of clinical candidate MR1704: A novel isothiazole based GPR40 agonist for diabetes
Okochi, Munetaka
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[3] Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes
Winters, Michael P.
Sui, Zhihua
Wall, Mark
Wang, Yuanping
Gunnet, Joseph
Leonard, James
Hua, Hong
Yan, Wen
Suckow, Arthur
Bell, Austin
Clapper, Wilmelenne
Jenkinson, Celia
Haug, Peter
Koudriakova, Tatiana
Huebert, Norman
Murray, William V.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 841 - 846
[4] Discovery and SAR of pyrrole derivatives as agonists of GPR120 for the treatment of type II diabetes
Winters, Michael
Lanter, James
Wall, Mark
Sui, Zhihua
Leonard, James
Gunnet, Joseph
Wang, Yuanping
Hua, Hong
Yan, Wen
Suckow, Arthur
Jenkinson, Celia
Haug, Peter
Bell, Austin
Clapper, Wilmelenne
Huebert, Norman
Murray, William
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[5] Free Fatty Acid Receptor GPR120 and Pathogenesis of Obesity and Type 2 Diabetes Mellitus
Mo, Xiu-Lei
Wei, Hong-Kui
Peng, Jian
Tao, Ya-Xiong
G PROTEIN-COUPLED RECEPTORS IN ENERGY HOMEOSTASIS AND OBESITY PATHOGENSIS, 2013, 114 : 251 - 276
[6] GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
Carullo, Gabriele
Mazzotta, Sarah
Vega-Holm, Margarita
Iglesias-Guerra, Fernando
Manuel Vega-Perez, Jose
Aiello, Francesca
Brizzi, Antonella
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4312 - 4332
[7] Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
Wang, Xuekun
Ji, Guoxia
Han, Xinyu
Hao, Huiran
Liu, Wenjing
Xue, Qidi
Guo, Qinghua
Wang, Shiben
Lei, Kang
Liu, Yadi
RSC ADVANCES, 2022, 12 (10) : 5732 - 5742
[8] Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
Wang, Xuekun
Li, Xu
Wei, Shiting
Wang, Min
Xu, Yao
Hu, Weidi
Gao, Zhenzhen
Liu, Renmin
Wang, Shiben
Ji, Guoxia
MOLECULES, 2022, 27 (24):
[9] Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes
Ji, Guoxia
Guo, Qinghua
Xue, Qidi
Kong, Ruifang
Wang, Shiben
Lei, Kang
Liu, Renmin
Wang, Xuekun
MOLECULES, 2021, 26 (22):
[10] Diphenyl Ether Derivatives as Novel GPR120 Agonists for the Treatment of Type 2 Diabetes Mellitus
Wang, Xuekun
Wei, Shiting
Wang, Min
Xu, Yao
Hu, Weidi
Niu, Mingyue
Wang, Shiben
Lei, Kang
Ji, Lusha
Liu, Renmin
Ji, Guoxia
CHEMISTRY & BIODIVERSITY, 2023, 20 (01)

← 1 2 3 4 →